Prescott General Partners

Latest statistics and disclosures from Prescott General Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CACC, CMPR, WRLD, W, YELP, and represent 99.75% of Prescott General Partners's stock portfolio.
  • Reduced shares in these 2 stocks: GIC (-$42M), Agex Therapeutics.
  • Sold out of its positions in Agex Therapeutics, GIC.
  • Prescott General Partners was a net seller of stock by $-42M.
  • Prescott General Partners has $1.8B in assets under management (AUM), dropping by 3.89%.
  • Central Index Key (CIK): 0001538653

Tip: Access up to 7 years of quarterly data

Positions held by Prescott General Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Prescott General Partners

Prescott General Partners holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Credit Acceptance (CACC) 47.8 $860M 1.6M 551.55
 View chart
Cimpress Shs Euro (CMPR) 19.2 $346M 3.9M 88.51
 View chart
World Acceptance (WRLD) 16.4 $295M 2.0M 144.98
 View chart
Wayfair Cl A (W) 14.4 $260M 3.8M 67.88
 View chart
Ye Cl A (YELP) 2.0 $36M 918k 39.40
 View chart
Lineage Cell Therapeutics In (LCTX) 0.2 $2.7M 1.9M 1.48
 View chart
Humacyte (HUMA) 0.1 $1.8M 568k 3.11
 View chart

Past Filings by Prescott General Partners

SEC 13F filings are viewable for Prescott General Partners going back to 2012

View all past filings